S'abonner

‘Bushfire Season’ in Australia: Determinants of Increases in Risk of Acute Coronary Syndromes and Takotsubo Syndrome - 05/12/22

Doi : 10.1016/j.amjmed.2022.08.013 
Gao Jing Ong, MBChB, PhD a, b, c, Alexander Sellers, MBBCh c, Gnanadevan Mahadavan, MBBS, PhD c, d, Thanh H. Nguyen, MD, PhD a, b, Matthew I. Worthley, MBBS, PhD b, c, Derek P. Chew, MBBS, PhD e, f, John D. Horowitz, MBBS, PhD a, b,
a Cardiology Research Laboratory, Basil Hetzel Institute for Translational Health Research, Queen Elizabeth Hospital, Adelaide, Australia 
b University of Adelaide, Adelaide, Australia 
c Cardiology Department, Central Adelaide Local Health Network, Adelaide, Australia 
d Cardiology Department, Northern Adelaide Local Health Network, Elizabeth Vale, Adelaide, Australia 
e South Australian Health and Medical Research Institute, Adelaide, Australia 
f College of Medicine and Public Health, Flinders University, Adelaide, Australia 

Requests for reprints should be addressed to John D. Horowitz, MBBS, PhD, University of Adelaide, Department of Cardiology, Basil Hetzel Institute for Translational Health Research, Queen Elizabeth Hospital, 28 Woodville Road Woodville South, Adelaide, SA, 5021, Australia.University of AdelaideDepartment of CardiologyBasil Hetzel Institute for Translational Health ResearchQueen Elizabeth Hospital28 Woodville Road Woodville SouthAdelaideSA,5021Australia

Abstract

Background

Climate change has resulted in an increase in ambient temperatures during the summer months as well as an increase in risk of associated air pollution and of potentially disastrous bushfires throughout much of the world. The increasingly frequent combination of elevated summer temperatures and bushfires may be associated with acute increases in risks of cardiovascular events, but this relationship remains unstudied. We evaluated the individual and cumulative impacts of daily fluctuations in temperature, fine particulate matter of less than 2.5 µm (PM2.5) pollution and presence of bushfires on incidence of acute coronary syndromes and Takotsubo syndrome.

Methods

From November 1, 2019, to February 28, 2020, all admissions with acute coronary syndromes or Takotsubo syndrome to South Australian tertiary public hospitals were evaluated. Univariate and combined associations were sought among each of 1) maximal daily temperature, 2) PM2.5 concentrations, and 3) presence of active bushfires within 200 km of the hospitals concerned.

Results

A total of 504 patients with acute coronary syndromes and 35 with Takotsubo syndrome were studied. In isolation, increasing temperature was associated (rs = 0.26, P = .005) with increased incidence of acute coronary syndromes, while there were similar, but nonsignificant correlations for PM2.5 and presence of bushfires. Combinations of all these risk factors were also associated with a doubling of risk of acute coronary syndromes. No significant associations were found for Takotsubo syndrome.

Conclusion

The combination of high temperatures, presence of bushfires and associated elevation of atmospheric PM2.5 concentrations represents a substantially increased risk for precipitation of acute coronary syndromes; this risk should be factored into health care planning including public education and acute hospital preparedness.

Le texte complet de cet article est disponible en PDF.

Keywords : Climate change, Global warming, Myocardial infarction, Takotsubo syndrome


Plan


 Funding: None.
 Conflicts of Interest: None.
 Authorship: All authors had access to the data and a role in writing this manuscript.


© 2022  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 136 - N° 1

P. 88-95 - janvier 2023 Retour au numéro
Article précédent Article précédent
  • Effectiveness and Safety of Direct Oral Anticoagulants Among Octogenarians with Venous Thromboembolism: An International Multidatabase Cohort Study
  • Antonios Douros, Frederike Basedow, Ying Cui, Jenny Dimakos, Jochen Walker, Dirk Enders, Vicky Tagalakis
| Article suivant Article suivant
  • The Prevention of COVID-19 in High-Risk Patients Using Tixagevimab–Cilgavimab (Evusheld): Real-World Experience at a Large Academic Center
  • Mohanad M. Al-Obaidi, Ahmet B. Gungor, Sandra E. Kurtin, Ann E. Mathias, Bekir Tanriover, Tirdad T. Zangeneh

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.